Doc type: Policy Directive
Compliance with this policy directive is mandatory.
Doc No.: PD2005_624
Functional Group - Sub Group:
Corporate Administration - Governance
Clinical/ Patient Services - Pharmaceutical
Clinical/ Patient Services - Medical Treatment
Clinical/ Patient Services - Nursing and Midwifery
Population Health - Pharmaceutical
Summary
This policy replaces Information Bulletin 93/31. Policy and risk management strategies to reduce the risk of error when oral methotrexate is prescribed, dispensed and administered for the treatment of inpatients or outpatients. Oral methotrexate is considered a high alert medicine due to the potential for error with its once a week dosage regimen, which is unusual compared to the daily dosing of most other medicines.
Date of Publication: 26 September 2005
Replaces: N/A
Author Branch: Clinical Safety, Quality and Governance
This document applies to: Area Health Services/Chief Executive Governed Statutory Health Corporation, Board Governed Statutory Health Corporations, Affiliated Health Organisations, Public Health System Support Division, Community Health Centres, Divisions of General Practice, Government Medical Officers, Private Hospitals and Day Procedure Centres, Private Nursing Homes, Public Hospitals
Audience: Administration, medical, pharmacy, nursing
Distributed to: Public Health System, Community Health Centres , Divisions of General Practice, Government Medical Officers, Health Professional Associations and Related Organisations, NSW Ambulance Service , NSW Department of Health, Public Hospitals, Private Hospitals and Day Procedure Centres , Private Nursing Homes, Tertiary Education Institutes
Review Date: 26 September 2011
Policy Manual: Not applicable
File No: 99/5022
Previous reference: N/A
Status: Active
File link: Methotrexate - Safe use of Oral Methotrexate
File size: 49Kb
|
 |
